Bharat Tewarie, MD, MBA
Chief Executive Officer
The Team Transforming the Industry
We are devoted to revolutionising early cancer detection — and that is why our team includes passionate, experienced experts with diverse industry backgrounds.
The Helio Leadership Team
United in our mission to change early cancer detection — researchers, operators, scientists, and more.
Jon Berarducci
Vice President of Commercial Operations
Sharon Liang
Vice President of Regulatory Affairs and Quality
Richard Van Etten, MD, PhD
Chief Medical Advisor
Wei Li, PhD
Chief Bioinformatics Advisor
Alex Brenner, MBA
Chief Financial Officer
Shivani Mahajan, PhD
Head of Computational Science
Our Board
Our Board
Bharat Tewarie (CEO) and Richard Van Etten (Chief Medical Advisor) also serve on the board — their full summaries appear in the Leadership Team section above.
Bharat Tewarie, MD, MBA
Chief Executive Officer
Shu Li, PhD
Executive Chairman
Terry Belmont, MPH
Board Member
Aarif Nakhooda, MBA
Board Member, Audit Committee Chair
Richard Van Etten, MD, PhD
Chief Medical Advisor
Hepatology Medical Advisors
Hepatology Medical Advisors
Mindie Nguyen, MD, MAS, AGAF, FAASLD
Hepatology Advisor and Lead Principal Investigator in CLiMB
Morris Sherman, MD, PhD
President of the International Liver Cancer Association
Ghassan K. Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
Yujin Hoshida, MD, PhD
Liver Tumor Translational Research Program, University of Texas Southwestern Medical Center
Robert Gish, MD
The Hepatitis B Foundation
Our Advisors
Our Advisors
Elizabeth Pusey, MD
Advisor
Robert Langer, ScD
Advisor
The Team Transforming the Industry
We are devoted to revolutionising early cancer detection — and that is why our team includes passionate, experienced experts with diverse industry backgrounds.